Stock Market News 30 December 2025

Freshpet stock slides as Fed minutes loom in thin year-end trade (FRPT)

NEW YORK, December 30, 2025, 1:59 PM ET — Regular session Freshpet, Inc. shares were down 3.5% at $60.84 by 1:59 p.m. ET on Tuesday, extending a choppy stretch for the pet food maker’s stock. The slide stood out against

30 December 2025

Federal Reserve·Market News·Stock Market

GMAB stock slides as Genmab scraps late-stage acasunlimab cancer therapy

NEW YORK, December 30, 2025, 1:54 PM ET — Regular session Genmab A/S’s U.S.-listed shares (GMAB) fell 3.3% to $31.45 in Tuesday’s regular session. The stock traded between $31.40 and $32.06 after opening at $31.98, with about 1.9 million shares

30 December 2025

Biotech News·Cancer Research·Investment Analysis·Pharmaceutical Industry·Stock Market

Lionsgate Studios (LION) stock slides today after insider sales hit the tape

NEW YORK, December 30, 2025, 13:49 ET — Regular session Lionsgate Studios Corp shares fell 3.4% on Tuesday, retreating after filings showed two top executives sold stock late this month. The stock was down 32.5 cents at $9.105, after trading

30 December 2025

Entertainment Industry·Financial News·Insider Trading·Investment·Stock Market

Energy Fuels stock falls today as UUUU pulls back after uranium sales beat, new contracts

NEW YORK, December 30, 2025, 13:43 ET — Regular session Shares of Energy Fuels Inc fell 3.5% to $14.55 in afternoon trading on Tuesday. The uranium miner lagged peers, with Uranium Energy down about 1.9% while Cameco was little changed

30 December 2025

Company News·Energy Sector·Investing·Stock Market·Uranium

AI stocks today: Nvidia AI21 buyout talk hits tape as Meta climbs on Manus deal

NEW YORK, December 30, 2025, 13:31 ET — Regular session Nvidia shares were nearly flat on Tuesday after an Israeli report said the AI-chip leader is in advanced talks to buy startup AI21 Labs for as much as $3 billion.

30 December 2025

Artificial Intelligence·Company News·Stock Market·Technology

ADMA Biologics stock slides nearly 4% as biotech weakens in thin year-end trade

NEW YORK, December 30, 2025, 13:35 ET — Regular session Shares of ADMA Biologics fell 3.7% to $18.40 in afternoon trading on Tuesday, a steeper drop than the broader biotech group. The SPDR S&P Biotech ETF was down about 1.3%.

30 December 2025

Biotech Industry·Financial Analysis·Investment News·Stock Market

Rivian stock drops nearly 6% as CEO share-sale filing hits the tape in thin year-end trade

NEW YORK, December 30, 2025, 13:30 ET — Regular session Rivian Automotive, Inc shares were down about 6% on Tuesday, pulling back in a light year-end session after a regulatory filing disclosed a stock sale by Chief Executive Officer Robert

30 December 2025

Company News·Electric Vehicles·Financial Analysis·Investing·Stock Market

Bitcoin price today steadies near $88,000 as Fed minutes loom; crypto stocks edge higher

NEW YORK, December 30, 2025, 1:29 PM ET — Regular session Bitcoin was up 0.8% at $88,320 on Tuesday afternoon in New York, steadying after recent choppy trading into the final days of the year. The move matters now because

30 December 2025

Bitcoin·Cryptocurrency·Federal Reserve·Market Analysis·Stock Market

Mineralys Therapeutics (MLYS) stock slides today as biotech weakens; FDA filing timeline in focus

NEW YORK, December 30, 2025, 13:38 ET — Regular session Shares of Mineralys Therapeutics Inc fell 3.3% to $35.61 by early afternoon on Tuesday, after touching a session low of $35.17. About 513,000 shares had changed hands, versus a previous

30 December 2025

Biotech Stocks·FDA News·Investment Analysis·Pharmaceutical Industry·Stock Market

Gold price rebounds today as Fed minutes near; GLD and Newmont stocks climb

NEW YORK, December 30, 2025, 13:25 ET — Regular session Gold prices rebounded on Tuesday and gold-linked shares traded higher in midday U.S. dealings, as investors positioned ahead of Federal Reserve minutes due later in the session. Spot gold was

30 December 2025

Economic News·Federal Reserve·Gold·Investment·Stock Market

Rhythm Pharmaceuticals (RYTM) stock falls today as biotech weakens; FDA decision stays in focus

NEW YORK, December 30, 2025, 13:33 ET — Regular session Rhythm Pharmaceuticals shares were down 4.2% at $107.85 at 1:33 p.m. ET on Tuesday, after trading as low as $106.65. The move matters because Rhythm is a single-product rare-disease biotech

30 December 2025

Biotech·Investing News·Pharmaceuticals·Stock Market

Warby Parker stock price today: WRBY falls nearly 4% in thin year-end trading

NEW YORK, December 30, 2025, 13:34 ET — Regular session Warby Parker Inc (WRBY) shares fell about 3.9% to $22.11 in early afternoon trading on Tuesday, after ending Monday at $23.00. The stock opened at $22.90 and traded between $21.87

30 December 2025

Business News·Financial Analysis·Investing·Retail Industry·Stock Market